ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

KNSA Kiniksa Pharmaceuticals Ltd

18.77
0.01 (0.05%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Kiniksa Pharmaceuticals Ltd KNSA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.05% 18.77 14:00:14
Open Price Low Price High Price Close Price Previous Close
18.57 18.41 18.865 18.77 18.76
more quote information »

Recent News

Date Time Source Heading
15/6/202406:27EDGAR2Form 8-K - Current report
06/6/202406:27EDGAR2Form 8-K - Current report
05/6/202406:01GLOBEKiniksa Pharmaceuticals to Present at Goldman Sachs 45th..
30/5/202407:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/5/202406:01GLOBEKiniksa Pharmaceuticals to Present at Bank of America..
23/4/202421:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
17/4/202406:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024..
02/4/202422:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for..
06/3/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:29EDGAR2Form 144 - Report of proposed sale of securities
01/3/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:35EDGAR2Form 8-K - Current report
28/2/202423:30GLOBEKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
28/2/202409:06EDGAR2Form 144 - Report of proposed sale of securities
22/2/202408:01GLOBEKiniksa Pharmaceuticals to Report Fourth Quarter and..
15/2/202408:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202407:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/1/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:37EDGAR2Form 8-K - Current report
04/1/202423:30GLOBEKiniksa Pharmaceuticals Provides Corporate Update
04/1/202408:55EDGAR2Form 144 - Report of proposed sale of securities
03/1/202408:01GLOBEKiniksa Pharmaceuticals to Present at 42nd Annual J.P...
12/12/202308:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202308:46EDGAR2Form 144 - Report of proposed sale of securities
03/11/202307:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202322:35EDGAR2Form 8-K - Current report
31/10/202322:30GLOBEKiniksa Pharmaceuticals Reports Third Quarter 2023 Financial..
25/10/202307:01GLOBEKiniksa Pharmaceuticals to Report Third Quarter 2023..
07/9/202309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202309:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202309:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202309:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202307:26EDGAR2Form 144 - Report of proposed sale of securities
19/8/202306:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/8/202306:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/8/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/7/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202307:14EDGAR2Form 144 - Report of proposed sale of securities
25/7/202321:40EDGAR2Form 8-K - Current report
25/7/202321:30GLOBEKiniksa Pharmaceuticals Reports Second Quarter 2023..
17/7/202322:00GLOBEKiniksa Pharmaceuticals to Report Second Quarter 2023..

Your Recent History

Delayed Upgrade Clock